Confirmation of the efficacy of vitamin B6 supplementation for McArdle disease by follow‐up muscle biopsy
- 13 February 2012
- journal article
- case report
- Published by Wiley in Muscle & Nerve
- Vol. 45 (3) , 436-440
Abstract
No effective treatment for McArdle disease exists.We report a Japanese patient with McArdle disease who was treated with vitamin B6 supplementation (60–90 mg/day). After treatment, increased muscle phosphorylase activity was confirmed by follow‐up muscle biopsy (3.8 times higher than pretreatment levels). Increased lactate levels were seen on the forearm exercise test, and regular work activities could be resumed. Vitamin B6 supplementation can enhance residual phosphorylase activity and improve insufficient anaerobic glycolysis of skeletal muscle. Muscle Nerve, 2012Keywords
This publication has 13 references indexed in Scilit:
- McArdle disease: a clinical reviewJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Pyridoxine-induced toxicity in rats: a stereological quantification of the sensory neuropathyExperimental Neurology, 2004
- A nonischemic forearm exercise test for McArdle diseaseAnnals of Neurology, 2002
- Genetic analysis of Japanese patients with myophosphorylase deficiency (McArdle's disease): single-codon deletion in exon 17 is the predominant mutationClinica Chimica Acta, 1995
- McArdle's disease: Molecular genetics and metabolic consequences of the phenotypeMuscle & Nerve, 1995
- Molecular Genetic Heterogeneity of Myophosphorylase Deficiency (McArdle's Disease)New England Journal of Medicine, 1993
- Acute sensory neuropathy‐neuronopathy from pyridoxine overdoseNeurology, 1987
- Sensory Neuropathy from Pyridoxine AbuseNew England Journal of Medicine, 1983
- Low Muscle Levels of Pyridoxine in McArdle's SyndromeThe American Journal of Medicine, 1983
- McArdle disease: The mystery of reappearing phosphorylase activity in muscle culture—A fetal isoenzymeAnnals of Neurology, 1978